When Leaders Don't Lead
Tuesday, October 19, 2021
I made greenback last week of the foreign quiet from our state's largest insurance company, Blue Cross Blue Shield, amongst consider to the pending antitrust short town betwixt the Attorney General too Partners Healthcare System. The impetus for my column was a rigid contestation past times the state's other insurers that the proposed bargain would live bad for the state's wellness attention organization too consumers.
But I didn't become far personal. The Boston Globe's Thomas Farragher has straight off done too thence inwards a column inwards which he asks the CEO of BCBS why the companionship has been still on the issue:
Apparently cured of laryngitis, he got on the telephone to explain.
“I’m non trying to live cute, but we’ve been neutral,’’ said Dreyfus, whose companionship accounts for close one-half of Partners’ commercial business. “It was our judgment that [Coakley’s office] got the best bargain they could. We weren’t going to substitute our judgment for theirs.’’
What Farragher makes clear is that quiet is non neutrality. Silence is assent. This CEO is sophisticated too thoughtful too understands that betoken too equally anybody inwards the state.
Dreyfus is improve than the center of that quote. A grouping of antitrust experts called flatly for rejection of the settlement. The state’s Health Policy Commission estimates the expansion could smother contest too hike wellness attention spending past times $49 meg a year. Dreyfus’s competitors, a grouping of other insurers, bring raised blood-red flags, too a coalition of Partners infirmary competitors bring said the bargain volition campaign upwards costs.
Andrew Dreyfus is a smart national phonation inwards America’s raging healthcare debate. He’s a sought-after speaker across the country, for goodness reason. He has held downwards costs. He’s been a proven leader. But non this time.
We cannot ever know what incents people to human activeness inwards for certain ways. We can, however, justice the import of their decisions. Last week, I compass it this way:
[BCBS'] actions over the years too its quiet straight off bring together it irrevocably amongst Partners equally an advocate for higher wellness attention costs inwards Massachusetts.
But I didn't become far personal. The Boston Globe's Thomas Farragher has straight off done too thence inwards a column inwards which he asks the CEO of BCBS why the companionship has been still on the issue:
Apparently cured of laryngitis, he got on the telephone to explain.
“I’m non trying to live cute, but we’ve been neutral,’’ said Dreyfus, whose companionship accounts for close one-half of Partners’ commercial business. “It was our judgment that [Coakley’s office] got the best bargain they could. We weren’t going to substitute our judgment for theirs.’’
What Farragher makes clear is that quiet is non neutrality. Silence is assent. This CEO is sophisticated too thoughtful too understands that betoken too equally anybody inwards the state.
Dreyfus is improve than the center of that quote. A grouping of antitrust experts called flatly for rejection of the settlement. The state’s Health Policy Commission estimates the expansion could smother contest too hike wellness attention spending past times $49 meg a year. Dreyfus’s competitors, a grouping of other insurers, bring raised blood-red flags, too a coalition of Partners infirmary competitors bring said the bargain volition campaign upwards costs.
Andrew Dreyfus is a smart national phonation inwards America’s raging healthcare debate. He’s a sought-after speaker across the country, for goodness reason. He has held downwards costs. He’s been a proven leader. But non this time.
We cannot ever know what incents people to human activeness inwards for certain ways. We can, however, justice the import of their decisions. Last week, I compass it this way:
[BCBS'] actions over the years too its quiet straight off bring together it irrevocably amongst Partners equally an advocate for higher wellness attention costs inwards Massachusetts.